Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
Includes $30M at Close to Refinance Existing Debt Facility LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan…